Annals of Surgical Oncology, ISSN 1068-9265, 12/2016, Volume 23, Issue S5, pp. 627 - 633
textabstractBackground: The purpose of this retrospective, population-based, cohort study was to identify patient and tumor characteristics that are associated...
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | MASTECTOMY | SURGERY | IRRADIATION | THERAPY | INVASIVE-CARCINOMA | ONCOLOGY | CANCER AMERICAN SOCIETY | LUMPECTOMY | NEEDLE CORE BIOPSY | RECURRENCE | STAGE-I | ASSOCIATION | Neoplasms, Multiple Primary - surgery | Breast Neoplasms - surgery | Carcinoma, Lobular - pathology | Neoplasms, Multiple Primary - metabolism | Receptors, Estrogen - metabolism | Blood Vessels - pathology | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Breast Neoplasms - metabolism | Neoplasm, Residual | Young Adult | Netherlands | Neoplasm Grading | Mastectomy, Segmental | Aged, 80 and over | Adult | Carcinoma, Ductal, Breast - pathology | Female | Registries | Retrospective Studies | Carcinoma, Intraductal, Noninfiltrating - surgery | Carcinoma, Ductal, Breast - metabolism | Carcinoma, Ductal, Breast - surgery | Carcinoma, Lobular - surgery | Neoplasm Invasiveness | Risk Factors | Margins of Excision | Tumor Burden | Neoplasms, Multiple Primary - pathology | Carcinoma, Intraductal, Noninfiltrating - pathology | Breast Neoplasms - pathology | Adolescent | Aged | Carcinoma, Lobular - metabolism | Lumpectomy | Analysis | Breast Oncology
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | MASTECTOMY | SURGERY | IRRADIATION | THERAPY | INVASIVE-CARCINOMA | ONCOLOGY | CANCER AMERICAN SOCIETY | LUMPECTOMY | NEEDLE CORE BIOPSY | RECURRENCE | STAGE-I | ASSOCIATION | Neoplasms, Multiple Primary - surgery | Breast Neoplasms - surgery | Carcinoma, Lobular - pathology | Neoplasms, Multiple Primary - metabolism | Receptors, Estrogen - metabolism | Blood Vessels - pathology | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Breast Neoplasms - metabolism | Neoplasm, Residual | Young Adult | Netherlands | Neoplasm Grading | Mastectomy, Segmental | Aged, 80 and over | Adult | Carcinoma, Ductal, Breast - pathology | Female | Registries | Retrospective Studies | Carcinoma, Intraductal, Noninfiltrating - surgery | Carcinoma, Ductal, Breast - metabolism | Carcinoma, Ductal, Breast - surgery | Carcinoma, Lobular - surgery | Neoplasm Invasiveness | Risk Factors | Margins of Excision | Tumor Burden | Neoplasms, Multiple Primary - pathology | Carcinoma, Intraductal, Noninfiltrating - pathology | Breast Neoplasms - pathology | Adolescent | Aged | Carcinoma, Lobular - metabolism | Lumpectomy | Analysis | Breast Oncology
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2017, Volume 12, Issue 1, p. e0171343
BACKGROUND: APOBEC3B was recently identified as a gain-of-function enzymatic source of mutagenesis, which may offer novel therapeutic options with molecules...
Breast tumors | Metastatic tumors | Brain metastasis | Breast cancer | Lung and intrathoracic tumors | Metastasis | Gene expression | Lymph nodes | Journal Article
Breast tumors | Metastatic tumors | Brain metastasis | Breast cancer | Lung and intrathoracic tumors | Metastasis | Gene expression | Lymph nodes | Journal Article
Journal Article
Value in Health, ISSN 1098-3015, 10/2018, Volume 21, pp. S247 - S248
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2009, Volume 361, Issue 7, pp. 653 - 663
This study involving women with early-stage breast cancer showed an association between the presence of isolated tumor cells or micrometastases in sentinel or...
SURVIVAL | MEDICINE, GENERAL & INTERNAL | NUMBER | LYMPH-NODE MICROMETASTASES | GUIDELINE TREATMENT | METASTASES | BIOPSY | FOLLOW-UP | PROGNOSTIC-SIGNIFICANCE | DISPLACEMENT | CARCINOMA | Lymph Node Excision | Breast Neoplasms - surgery | Lymph Nodes - pathology | Follow-Up Studies | Humans | Middle Aged | Treatment Outcome | Breast Neoplasms - drug therapy | Case-Control Studies | Disease-Free Survival | Breast Neoplasms - pathology | Lymphatic Metastasis - pathology | Age of Onset | Aged, 80 and over | Axilla | Adult | Female | Aged | Sentinel Lymph Node Biopsy | Chemotherapy, Adjuvant | Neoplasm Staging | Breast cancer | Diagnosis | Metastasis | Research | Patient outcomes | Lymphatic system | Biopsy | Dissection | Cancer therapies | Tumors
SURVIVAL | MEDICINE, GENERAL & INTERNAL | NUMBER | LYMPH-NODE MICROMETASTASES | GUIDELINE TREATMENT | METASTASES | BIOPSY | FOLLOW-UP | PROGNOSTIC-SIGNIFICANCE | DISPLACEMENT | CARCINOMA | Lymph Node Excision | Breast Neoplasms - surgery | Lymph Nodes - pathology | Follow-Up Studies | Humans | Middle Aged | Treatment Outcome | Breast Neoplasms - drug therapy | Case-Control Studies | Disease-Free Survival | Breast Neoplasms - pathology | Lymphatic Metastasis - pathology | Age of Onset | Aged, 80 and over | Axilla | Adult | Female | Aged | Sentinel Lymph Node Biopsy | Chemotherapy, Adjuvant | Neoplasm Staging | Breast cancer | Diagnosis | Metastasis | Research | Patient outcomes | Lymphatic system | Biopsy | Dissection | Cancer therapies | Tumors
Journal Article
PLoS genetics, ISSN 1553-7390, 2013, Volume 9, Issue 3, p. e1003212
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To identify further cancer risk-modifying loci, we performed a...
CONSORTIUM | COMMON VARIANTS | POPULATION | INVESTIGATORS | MODIFIERS | SUBTYPES | SUSCEPTIBILITY ALLELES | GENETICS & HEREDITY | GENETIC-VARIANTS | SELECTION | ZNF365 | Genetic Predisposition to Disease | Genome-Wide Association Study | Prognosis | Humans | Middle Aged | Risk Factors | Ovarian Neoplasms - pathology | Genotype | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Female | Heterozygote | Polymorphism, Single Nucleotide | Mutation | BRCA2 Protein - genetics | Gene mutations | Genomics | Physiological aspects | Breast cancer | Genetic aspects | Research | Risk factors | Ovarian cancer | Cancer | Cà ncer d'ovari | Cà ncer de mama | Malalties heredità ries | Genètica humana | Genetic diseases | Human genetics | Life Sciences | Medical and Health Sciences | Medicin och hälsovetenskap | Medical research
CONSORTIUM | COMMON VARIANTS | POPULATION | INVESTIGATORS | MODIFIERS | SUBTYPES | SUSCEPTIBILITY ALLELES | GENETICS & HEREDITY | GENETIC-VARIANTS | SELECTION | ZNF365 | Genetic Predisposition to Disease | Genome-Wide Association Study | Prognosis | Humans | Middle Aged | Risk Factors | Ovarian Neoplasms - pathology | Genotype | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Female | Heterozygote | Polymorphism, Single Nucleotide | Mutation | BRCA2 Protein - genetics | Gene mutations | Genomics | Physiological aspects | Breast cancer | Genetic aspects | Research | Risk factors | Ovarian cancer | Cancer | Cà ncer d'ovari | Cà ncer de mama | Malalties heredità ries | Genètica humana | Genetic diseases | Human genetics | Life Sciences | Medical and Health Sciences | Medicin och hälsovetenskap | Medical research
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 482 - 12
textabstractMale breast cancer (MBC) is rare and largely hormonally driven. Here, the authors examine the action of steroid hormone receptors in male and...
FOXA1 | ANDROGEN RECEPTOR | TAMOXIFEN | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | TRANSCRIPTIONAL PROGRAM | PROGESTERONE-RECEPTOR | EXPRESSION | ESTROGEN-RECEPTOR | ER-ALPHA | REVEALS | Chromatin - metabolism | Humans | Middle Aged | Receptors, Androgen - metabolism | Male | Survival Rate | Receptors, Glucocorticoid - metabolism | Breast Neoplasms - metabolism | Hepatocyte Nuclear Factor 3-alpha - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms, Male - metabolism | Aged, 80 and over | Adult | Estrogen Receptor alpha - metabolism | Female | Aged | GATA3 Transcription Factor - metabolism | Binding | Chromatin | Glucocorticoids | Estrogens | Crosstalk | Estrogen | Breast cancer | Genomes | Gene expression | Receptors | Androgens | GATA-3 protein | Breast | Progesterone | Tumors | Cancer | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
FOXA1 | ANDROGEN RECEPTOR | TAMOXIFEN | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | TRANSCRIPTIONAL PROGRAM | PROGESTERONE-RECEPTOR | EXPRESSION | ESTROGEN-RECEPTOR | ER-ALPHA | REVEALS | Chromatin - metabolism | Humans | Middle Aged | Receptors, Androgen - metabolism | Male | Survival Rate | Receptors, Glucocorticoid - metabolism | Breast Neoplasms - metabolism | Hepatocyte Nuclear Factor 3-alpha - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms, Male - metabolism | Aged, 80 and over | Adult | Estrogen Receptor alpha - metabolism | Female | Aged | GATA3 Transcription Factor - metabolism | Binding | Chromatin | Glucocorticoids | Estrogens | Crosstalk | Estrogen | Breast cancer | Genomes | Gene expression | Receptors | Androgens | GATA-3 protein | Breast | Progesterone | Tumors | Cancer | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2008, Volume 100, Issue 22, pp. 1574 - 1580
There are many reports on the frequency of non-sentinel lymph node involvement when isolated tumor cells are found in the sentinel node, but results and...
AMERICAN-JOINT-COMMITTEE | ADDITIONAL AXILLARY METASTASES | SLN BIOPSY | ONCOLOGY | DISSECTION | CLINICAL-IMPLICATIONS | MICROMETASTASES | ISOLATED TUMOR-CELLS | FALSE-NEGATIVE RATES | PREDICTIVE FACTORS | STAGE MIGRATION | Lymph Node Excision | Lymph Nodes - pathology | Risk Assessment | Breast Neoplasms - pathology | Humans | Axilla | Carcinoma, Ductal, Breast - pathology | Female | Lymphatic Metastasis | Sentinel Lymph Node Biopsy | Breast cancer | Diagnosis | Health aspects | Surgery | Risk factors | Lymph nodes | Oncology | Lymphatic system | Metastasis | Cellular biology | Review
AMERICAN-JOINT-COMMITTEE | ADDITIONAL AXILLARY METASTASES | SLN BIOPSY | ONCOLOGY | DISSECTION | CLINICAL-IMPLICATIONS | MICROMETASTASES | ISOLATED TUMOR-CELLS | FALSE-NEGATIVE RATES | PREDICTIVE FACTORS | STAGE MIGRATION | Lymph Node Excision | Lymph Nodes - pathology | Risk Assessment | Breast Neoplasms - pathology | Humans | Axilla | Carcinoma, Ductal, Breast - pathology | Female | Lymphatic Metastasis | Sentinel Lymph Node Biopsy | Breast cancer | Diagnosis | Health aspects | Surgery | Risk factors | Lymph nodes | Oncology | Lymphatic system | Metastasis | Cellular biology | Review
Journal Article
Virchows Archiv, ISSN 0945-6317, 01/2019, Volume 474, Issue 2, pp. 247 - 251
textabstractSeveral models have been described as potential mechanisms for the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer (IBC)....
Breast . Ductal carcinoma in situ . Progression . Genomics | Progression | Breast | Pathology | Ductal carcinoma in situ | Medicine & Public Health | Genomics | GENETIC-HETEROGENEITY | PATHOLOGY | Medical research | Carcinoma, Ductal | Medicine, Experimental | Development and progression | Genetic aspects | Comparative analysis | Cancer | Tumor cells | Invasiveness | Therapeutic applications | Breast cancer | Mutation | Patients | Tumors | Brief Report
Breast . Ductal carcinoma in situ . Progression . Genomics | Progression | Breast | Pathology | Ductal carcinoma in situ | Medicine & Public Health | Genomics | GENETIC-HETEROGENEITY | PATHOLOGY | Medical research | Carcinoma, Ductal | Medicine, Experimental | Development and progression | Genetic aspects | Comparative analysis | Cancer | Tumor cells | Invasiveness | Therapeutic applications | Breast cancer | Mutation | Patients | Tumors | Brief Report
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 02/2019, Volume 175, Issue 2, pp. 451 - 458
textabstractPurpose The estrogen (ER), progesterone (PR), and HER2 status are essential in guiding treatment decisions in breast cancer patients. In daily...
Discordance · Breast cancer · Estrogen · Progesterone · Human epidermal growth factor receptor 2 · Diagnostics | Breast cancer | Progesterone | Diagnostics | Human epidermal growth factor receptor 2 | Discordance | Estrogen | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | BREAST-CANCER PATIENTS | CORE NEEDLE-BIOPSY | Epidemiology
Discordance · Breast cancer · Estrogen · Progesterone · Human epidermal growth factor receptor 2 · Diagnostics | Breast cancer | Progesterone | Diagnostics | Human epidermal growth factor receptor 2 | Discordance | Estrogen | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | BREAST-CANCER PATIENTS | CORE NEEDLE-BIOPSY | Epidemiology
Journal Article
BMC Cancer, ISSN 1471-2407, 02/2016, Volume 16, Issue 1, p. 78
textabstractBackground The high incidence of breast cancer has sparked the development of novel targeted and personalized therapies. Personalization of cancer...
FAC chemotherapy | Ex vivo sensitivity | Breast cancer | Organotypic tumor tissue slices | Tissue culture method | CYCLOPHOSPHAMIDE | DOXORUBICIN | MODEL | FLUOROURACIL | CHEMOTHERAPY | PACLITAXEL | THERAPY | ONCOLOGY | CELL-CULTURE | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Tumor Cells, Cultured - drug effects | Antineoplastic Agents - administration & dosage | Breast Neoplasms - drug therapy | Drug Resistance, Neoplasm - genetics | Fluorouracil - administration & dosage | Breast Neoplasms - pathology | Female | Tissue Culture Techniques - methods | Doxorubicin - administration & dosage | Drug Screening Assays, Antitumor | Precision Medicine | Complications and side effects | Anthracyclines | Chemotherapy | Usage | Development and progression | Research | Drug therapy | Health aspects | Cancer
FAC chemotherapy | Ex vivo sensitivity | Breast cancer | Organotypic tumor tissue slices | Tissue culture method | CYCLOPHOSPHAMIDE | DOXORUBICIN | MODEL | FLUOROURACIL | CHEMOTHERAPY | PACLITAXEL | THERAPY | ONCOLOGY | CELL-CULTURE | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Tumor Cells, Cultured - drug effects | Antineoplastic Agents - administration & dosage | Breast Neoplasms - drug therapy | Drug Resistance, Neoplasm - genetics | Fluorouracil - administration & dosage | Breast Neoplasms - pathology | Female | Tissue Culture Techniques - methods | Doxorubicin - administration & dosage | Drug Screening Assays, Antitumor | Precision Medicine | Complications and side effects | Anthracyclines | Chemotherapy | Usage | Development and progression | Research | Drug therapy | Health aspects | Cancer
Journal Article
11.
Full Text
Prognostic factors in metaplastic carcinoma of the breast: A multi-institutional study
British Journal of Cancer, ISSN 0007-0920, 01/2015, Volume 112, Issue 2, pp. 283 - 289
textabstractBackground: Metaplastic breast carcinoma (MBC) is a rare type of breast cancer that has basal-like characteristics and is perceived to have poorer...
Metaplastic carcinoma | Prognosis | Outcome | Tumour type | Race | Breast cancer | Grade | metaplastic carcinoma | WORSE PROGNOSIS | race | NEOPLASMS | SARCOMATOID CARCINOMA | tumour type | PHENOTYPE | breast cancer | prognosis | CANCER | TUMORS | CARTILAGE | FEATURES | ONCOLOGY | grade | RECURRENCE | outcome | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Lymphatic Metastasis | Carcinoma, Ductal, Breast - mortality | Breast Neoplasms - therapy | Carcinoma, Ductal, Breast - therapy | Breast Neoplasms - pathology | Aged, 80 and over | Adult | Breast Neoplasms - mortality | Female | Aged | Carcinoma, Ductal, Breast - secondary | Clinical Study
Metaplastic carcinoma | Prognosis | Outcome | Tumour type | Race | Breast cancer | Grade | metaplastic carcinoma | WORSE PROGNOSIS | race | NEOPLASMS | SARCOMATOID CARCINOMA | tumour type | PHENOTYPE | breast cancer | prognosis | CANCER | TUMORS | CARTILAGE | FEATURES | ONCOLOGY | grade | RECURRENCE | outcome | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Lymphatic Metastasis | Carcinoma, Ductal, Breast - mortality | Breast Neoplasms - therapy | Carcinoma, Ductal, Breast - therapy | Breast Neoplasms - pathology | Aged, 80 and over | Adult | Breast Neoplasms - mortality | Female | Aged | Carcinoma, Ductal, Breast - secondary | Clinical Study
Journal Article
Nature communications, ISSN 2041-1723, 2016, Volume 7, Issue 1, p. 12910
A recent comprehensive whole genome analysis of a large breast cancer cohort was used to link known and novel drivers and substitution signatures to the...
EXPRESSION PATTERNS | AMPLIFICATION | LANDSCAPE | MULTIDISCIPLINARY SCIENCES | TP53 MUTATION | GENES | C-MYC | CARCINOMAS | E-CADHERIN | TUMORS | SOMATIC MUTATIONS | Life Sciences | Medicinsk genetik | Basic Medicine | Medical Genetics | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Cell and Molecular Biology | Klinisk medicin | Cancer and Oncology | Cell- och molekylärbiologi | Cancer och onkologi
EXPRESSION PATTERNS | AMPLIFICATION | LANDSCAPE | MULTIDISCIPLINARY SCIENCES | TP53 MUTATION | GENES | C-MYC | CARCINOMAS | E-CADHERIN | TUMORS | SOMATIC MUTATIONS | Life Sciences | Medicinsk genetik | Basic Medicine | Medical Genetics | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Cell and Molecular Biology | Klinisk medicin | Cancer and Oncology | Cell- och molekylärbiologi | Cancer och onkologi
Journal Article
BMC Cancer, ISSN 1471-2407, 05/2017, Volume 17, Issue 1, pp. 336 - 7
textabstractBackground: Cosmetic result following breast conserving surgery (BCS) for cancer influences quality of life and psychosocial functioning in breast...
SURGERY | SYSTEM | AESTHETIC EVALUATION | BOOST | ONCOLOGY | SCANNER | CONSERVING THERAPY | RADIATION-THERAPY | Models, Theoretical | Breast Neoplasms - surgery | Breast Neoplasms - pathology | Ultrasonography, Mammary - methods | Humans | Breast - diagnostic imaging | Decision Support Techniques | Female | Tumor Burden | Mammography - methods | Breast - pathology | Mastectomy, Segmental - methods | Breast Cancer Patient | Cosmetic Outcome | Automate Breast Volume Scanner | Breast Conserve Surgery | Oncoplastic Surgery
SURGERY | SYSTEM | AESTHETIC EVALUATION | BOOST | ONCOLOGY | SCANNER | CONSERVING THERAPY | RADIATION-THERAPY | Models, Theoretical | Breast Neoplasms - surgery | Breast Neoplasms - pathology | Ultrasonography, Mammary - methods | Humans | Breast - diagnostic imaging | Decision Support Techniques | Female | Tumor Burden | Mammography - methods | Breast - pathology | Mastectomy, Segmental - methods | Breast Cancer Patient | Cosmetic Outcome | Automate Breast Volume Scanner | Breast Conserve Surgery | Oncoplastic Surgery
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 07/2016, Volume 158, Issue 1, pp. 179 - 187
textabstractDuctal carcinoma in situ (DCIS) is a precursor of invasive breast carcinoma (IBC). The DCIS component is often more extensive than the invasive...
Oncology | Ductal carcinoma in situ | Prevalence | Medicine & Public Health | Breast cancer subtypes | MOLECULAR PHENOTYPES | RISK | ESTROGEN-RECEPTOR | ONCOLOGY | DCIS | HER2 STATUS | RECURRENCE | PROGESTERONE-RECEPTOR | PROGNOSTIC-SIGNIFICANCE | EXPRESSION | AMERICAN SOCIETY | Breast Neoplasms - classification | Breast Neoplasms - surgery | Carcinoma, Ductal, Breast - surgery | Receptors, Estrogen - metabolism | Humans | Middle Aged | Carcinoma, Intraductal, Noninfiltrating - metabolism | Margins of Excision | Receptor, ErbB-2 - metabolism | Breast Neoplasms - metabolism | Young Adult | Netherlands | Carcinoma, Intraductal, Noninfiltrating - pathology | Breast Neoplasms - pathology | Mastectomy, Segmental | Aged, 80 and over | Adult | Carcinoma, Ductal, Breast - pathology | Female | Aged | Carcinoma, Intraductal, Noninfiltrating - surgery | Carcinoma, Ductal, Breast - metabolism | Cohort Studies | Lumpectomy | Carcinoma | Analysis | Oncology, Experimental | Breast cancer | Research | Cancer | Epidemiology
Oncology | Ductal carcinoma in situ | Prevalence | Medicine & Public Health | Breast cancer subtypes | MOLECULAR PHENOTYPES | RISK | ESTROGEN-RECEPTOR | ONCOLOGY | DCIS | HER2 STATUS | RECURRENCE | PROGESTERONE-RECEPTOR | PROGNOSTIC-SIGNIFICANCE | EXPRESSION | AMERICAN SOCIETY | Breast Neoplasms - classification | Breast Neoplasms - surgery | Carcinoma, Ductal, Breast - surgery | Receptors, Estrogen - metabolism | Humans | Middle Aged | Carcinoma, Intraductal, Noninfiltrating - metabolism | Margins of Excision | Receptor, ErbB-2 - metabolism | Breast Neoplasms - metabolism | Young Adult | Netherlands | Carcinoma, Intraductal, Noninfiltrating - pathology | Breast Neoplasms - pathology | Mastectomy, Segmental | Aged, 80 and over | Adult | Carcinoma, Ductal, Breast - pathology | Female | Aged | Carcinoma, Intraductal, Noninfiltrating - surgery | Carcinoma, Ductal, Breast - metabolism | Cohort Studies | Lumpectomy | Carcinoma | Analysis | Oncology, Experimental | Breast cancer | Research | Cancer | Epidemiology
Journal Article